Miracle Mile Advisors’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$29.1M Sell
114,607
-1,293
-1% -$301K 0.34% 64
2026
Q1
$28.3M Sell
115,900
-2,389
-2% -$556K 0.39% 63
2025
Q4
$24.5M Sell
118,289
-1,040
-0.9% -$206K 0.35% 64
2025
Q3
$22.1M Sell
119,329
-8,477
-7% -$1.45M 0.33% 63
2025
Q2
$19.5M Buy
127,806
+11,003
+9% +$1.69M 0.33% 61
2025
Q1
$19.4M Sell
116,803
-2,397
-2% -$375K 0.39% 50
2024
Q4
$17.2M Buy
119,200
+55,200
+86% +$8.55M 0.35% 57
2024
Q3
$10.4M Buy
64,000
+312
+0.5% +$49.7K 0.24% 65
2024
Q2
$9.31M Sell
63,688
-1,592
-2% -$237K 0.23% 71
2024
Q1
$10.3M Buy
65,280
+6,383
+11% +$1.02M 0.26% 72
2023
Q4
$9.23M Buy
58,897
+32,015
+119% +$4.91M 0.25% 70
2023
Q3
$4.19M Sell
26,882
-1,847
-6% -$305K 0.13% 106
2023
Q2
$4.76M Sell
28,729
-10,012
-26% -$1.62M 0.14% 105
2023
Q1
$6M Sell
38,741
-1,288
-3% -$208K 0.19% 96
2022
Q4
$7.07M Buy
40,029
+21,467
+116% +$3.71M 0.24% 83
2022
Q3
$3.03M Sell
18,562
-169
-0.9% -$28.6K 0.14% 110
2022
Q2
$3.33M Buy
18,731
+4,705
+34% +$838K 0.16% 110
2022
Q1
$2.49M Sell
14,026
-34,173
-71% -$5.81M 0.11% 139
2021
Q4
$8.24M Buy
48,199
+2,249
+5% +$368K 0.32% 65
2021
Q3
$7.42M Buy
45,950
+689
+2% +$118K 0.36% 64
2021
Q2
$7.46M Buy
45,261
+361
+0.8% +$59.8K 0.4% 57
2021
Q1
$7.38M Sell
44,900
-1,458
-3% -$236K 0.42% 55
2020
Q4
$7.3M Buy
46,358
+3,215
+7% +$474K 0.45% 55
2020
Q3
$6.42M Buy
43,143
+4,787
+12% +$708K 0.45% 54
2020
Q2
$5.39M Sell
38,356
-1,450
-4% -$211K 0.44% 51
2020
Q1
$5.22M Sell
39,806
-3,205
-7% -$455K 0.56% 38
2019
Q4
$6.27M Sell
43,011
-44,977
-51% -$6.1M 0.43% 51
2019
Q3
$11.4M Buy
87,988
+33,624
+62% +$4.43M 0.8% 32
2019
Q2
$7.57M Buy
54,364
+11,339
+26% +$1.57M 0.57% 38
2019
Q1
$6.01M Buy
43,025
+37,418
+667% +$5.01M 0.48% 44
2018
Q4
$724K Buy
5,607
+1,663
+42% +$232K 0.09% 76
2018
Q3
$545K Buy
3,944
+175
+5% +$23.3K 0.05% 119
2018
Q2
$457K Buy
3,769
+82
+2% +$10.2K 0.04% 118
2018
Q1
$472K Buy
3,687
+377
+11% +$51K 0.05% 109
2017
Q4
$462K Sell
3,310
-656
-17% -$91.4K 0.07% 62
2017
Q3
$516K Buy
3,966
+270
+7% +$35.8K 0.09% 46
2017
Q2
$489K Sell
3,696
-666
-15% -$85K 0.09% 45
2017
Q1
$543K Buy
4,362
+679
+18% +$81.1K 0.1% 47
2016
Q4
$424K Buy
3,683
+1,378
+60% +$159K 0.1% 52
2016
Q3
$272K Buy
2,305
+16
+0.7% +$1.94K 0.07% 62
2016
Q2
$282K Buy
+2,289
New +$260K 0.09% 47
2016
Q1
Sell
-2,297
Closed -$236K 60
2015
Q4
$236K Sell
2,297
-174
-7% -$17.5K 0.08% 46
2015
Q3
$231K Buy
+2,471
New +$239K 0.08% 49

Other funds holding JNJ

Miracle Mile Advisors's JNJ Position: Q2 2026 in Review

Miracle Mile Advisors reduced its Johnson & Johnson (JNJ) stake by 1.1% in Q2 2026, selling an estimated $301K and leaving 114,607 shares worth $29.1M. The position accounts for 0.34% of the portfolio, ranked #64.

Miracle Mile Advisors first reported a position in JNJ in Q3 2015 and has held it in 43 quarters since. 1,985 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Miracle Mile Advisors held 114,607 shares of Johnson & Johnson worth $29.1M as of Q2 2026.
  • Miracle Mile Advisors sold 1,293 Johnson & Johnson shares in Q2 2026, an estimated $301K.
  • Johnson & Johnson made up 0.34% of Miracle Mile Advisors's portfolio in Q2 2026, its #64 holding.
  • Miracle Mile Advisors first reported a position in Johnson & Johnson in Q3 2015 and has held it in 43 quarters since.
  • 1,985 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Miracle Mile Advisors's 13F filing for Q2 2026, filed 22 Jul 2026.